Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proteome Software is a bioinformatics company specializing in the development of advanced software tools for mass spectrometry-based proteomics research. The company's flagship product suite, Scaffold, is widely used by researchers to visualize, validate, and annotate complex proteomics data, facilitating the identification and quantification of proteins. Their solutions support various workflows, including post-translational modification (PTM) analysis, data-independent acquisition (DIA), and small molecule identification. In September 2024, the company was acquired by Bruker to enhance its post-processing software capabilities for the timsTOF platform. Despite the acquisition, the software continues to support data from all major mass spectrometry hardware vendors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proteome Software.